Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Annually, our Advisors make a personal financial contribution to cover LSC’s administrative costs, allowing us to channel money raised from our event fundraisers, Corporate Membership Program, and from individuals to our partner organizations.
Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.
PHILADELPHIA BOARD OF ADVISORS
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Tom Anderson
CEO – SwanBio Therapeutics
Scott Applebaum
Chief Legal Officer & Corporate Secretary – VectivBio AG
Lou Beardell
Partner – Morgan Lewis & Bockius
Glenn Blumenfeld
Principal – Tactix Real Estate Advisors, LLC
Carrie Bourdow
President & CEO – TrevenaDerek Bowen
Vice President – Blackfynn
Scott Braunstein
CEO – Marinus Therapeutics
Christopher Burns
President & CEO – Venatorx
Rachael Bushey
Partner – Troutman PepperChip Cale
General Counsel – Passage Bio
Ron Cariola
International Director – JLL
Barb Carlin
Managing Director - MidAtlantic – Danforth Advisors
Brett Ciarelli
Executive Director – Morgan Stanley Private Wealth Management
John Crowley
Chairman and CEO – Amicus Therapeutics
Jeff Dayno
Chief Medical Officer – Harmony Biosciences
Phillip Duffy
Korn Ferry
Phillip Duffy
Korn Ferry
John Fry
President – Drexel UniversitySteven Gelone
President & COO – Nabriva Therapeutics
John Grady
Sr. VP Development – Wexford Science + Technology
Daniel Griffing
Managing Partner – Griffing Speizer & Partners LLCDaniel Hayes
Principal, Life Sciences – CliftonLarsonAllen LLP
Stephen Hurly
CEO – LAVA Therapeutics
Steve Jannetta
Partner – Morgan Lewis & Bockius
Steven Kelly
President & CEO – Carisma Therapeutics
Martin Lehr
CEO – Context Therapeutics
Evan Loh
CEO – Paratek Pharmaceuticals
Kevin Mahoney
CEO – University of Pennsylvania Health System
Francesco Maria Lavino
CEO – F2G Ltd
John Maslowski
CEO – Castle Creek Biosciences, Inc.
Steven Nichtberger
CEO, President & Chairman – Cabaletta Bio
Shawn Patrick O'Brien
CEO – Genomind
Matthew Pearson
Partner – Akin Gump
Mike Pellini
Managing Partner – Section 32
Robert Radie
CEO & Chairman – Neuraptive Therapeutics
Maryellen Royle
Partner – EvokeKYNE
Gary Sender
Independent Board Member – Harmony Biosciences, Elucida Oncology
Kathleen Shay
Partner – Duane Morris
Bruce Shook
CEO – Vesper Medical
Steve Simpson
Partner – EY
Thomas Stenberg
Area Vice President - Production – Gallagher
Dan Strauss
Partner – Klein Hersh International
Tyler Vandegrift
Managing Director – JLLMelanie Wong
Senior Manager, People Team – Century Therapeutics